Answers are grounded in this paper and cite their sources.
Characterization of the Rc-o319 S-protein shows specialized binding to ACE2 in Rhinolophus cornutus, highlighting evolutionary adaptation.
Sarbecoviruses, represented by SARS-CoV-1 and SARS-CoV-2, utilize their spike (S) proteins to bind host ACE2 receptors and initiate infection. Here, we characterize the S-protein of Rc-o319, a sarbecovirus identified in Japanese Rhinolophus cornutus bats, which exhibits highly restricted receptor specificity. Functional assays demonstrate that Rc-o319 S-protein preferentially utilizes its cognate R. cornutus ACE2 (bACE2R.cor). Cryo-EM structures reveal two locked prefusion conformations of the Rc-o319 S-trimer and identify a novel Type-4 receptor-binding domain (RBD), featuring a distinct beta-loop (BL) element within the receptor-binding motif (RBM). The Rc-o319-RBD:bACE2R.cor complex structure reveals unique contact features, including specialized BL mediates interactions with bACE2R.cor and interactions mediated a bACE2R.cor glycan. Structure-guided mutagenesis demonstrates that the BL-RBM-loop co-adaptation within the Rc-o319 S-protein poses a barrier to hACE2 utilization. Comparative assays further show that the bACE2R.cor receptor supports only a subset of sarbecoviruses, highlighting its restricted sarbecovirus compatibility. Our findings establish the Rc-o319 S-protein as a structurally and functionally specialized adaptation to R. cornutus ACE2 and underscore the structural constraints limiting its cross-species transmission potential.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: